Metraipolis › archive › dc_fc789d1fc19d

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma — Europe PMC PMID:42306568

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42306568
DOI
10.1016/j.omton.2026.201239
License (as archived)
solo-consultazione
Archived
2026-11-01T10:28:46.663Z
SHA-256 of the archived text
09fb4e21946f6a4d78a869ad4468bc6abd9014cfd8f08dc6c1ffd7720fe2414f
Stable URL of this page
https://metraipolis.com/documento/dc_fc789d1fc19d

How to cite

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma — Europe PMC PMID:42306568 — Europe PMC (en), https://europepmc.org/article/MED/42306568 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc789d1fc19d (Metraipolis archive dc_fc789d1fc19d, sha256 09fb4e21946f6a4d78a869ad4468bc6abd9014cfd8f08dc6c1ffd7720fe2414f)
BibTeX
@misc{dcfc789d1fc19d,
  title = {Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma — Europe PMC PMID:42306568},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42306568},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc789d1fc19d; sha256 09fb4e21946f6a4d78a869ad4468bc6abd9014cfd8f08dc6c1ffd7720fe2414f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306568. Agents can read the archived copy with the MCP tool read_document.